Steps to make the people who fetch articles for you happy:
1) UTFSE for your article here and at other boards. You'd be surprised at the myriad articles that we have already fetched. If you find it somewhere else, and it's important for the community, start a thread about it or post it in the "Articles of Interest" thread.
2) Make sure that the article is already in digital format. If it isn't, include that fact with your request.
3) Color your requests blue, and provide the following required information so that we can use our limited time wisely retrieving your article instead of searching for the necessary information. Your article request probably won't be filled if you don't include a DOI. You can simply fill in the form below.Code: [Select][color=blue]Authors
[b]Article Title[/b]
[i]Journal Title[/i] [b]Year[/b], [u]Volume[/u](Issue):Page range
DOI:____
PMID:____
[u]Abstract[/u]
If you can find the abstract, paste it here.[/color]
An Example using a previously fetched article (not the greatest because Synlett uses the year as its volume number, but you get the point):
Li-Xiong Shao, Min Shi
N-Bromosuccinimide and Lithium Bromide: An Efficient Combination for the Dibromination of Carbon-Carbon Unsaturated Bonds
Synlett 2006, 2006(:1269-1271
DOI: 10.1055/s-2006-941558
PMID: None
Abstract
Compounds possessing unsaturated bonds such as alkenes, alkynes, allenes, and methylenecyclopropanes (MCPs) can be dibrominated within minutes by NBS and lithium bromide in THF at room temperature in good to excellent yields under mild conditions.
java
- Global Moderator
- Foundress Queen
- Posts: 783
4studiesonly
- Larvae
- Posts: 28
Seeking this pdf in english
H. Emde, Helv Chim Acta, 12, 365-405 (1929)
Which Rhodium referrs to here: parazite.pp.fi/hiveboard/crystal/000443198.html
And is found in German here: toxi.dl.uni-leipzig.de/servlets/MCRFileNodeServlet/PGSToxi_derivate_00000319/160_Schlecker_Harald.pdf;jsessionid=jdc6uv7gieln?hosts=local
Rhodium states it comes from Hermann Emde's Ephedrine Chemistry Treatise and it can be partly found at: erowid.org/archive/rhodium/chemistry/ephedrine.html at the end...
My first request of something so i hope i made it as rules state....
Thank you
H. Emde, Helv Chim Acta, 12, 365-405 (1929)
Which Rhodium referrs to here: parazite.pp.fi/hiveboard/crystal/000443198.html
And is found in German here: toxi.dl.uni-leipzig.de/servlets/MCRFileNodeServlet/PGSToxi_derivate_00000319/160_Schlecker_Harald.pdf;jsessionid=jdc6uv7gieln?hosts=local
Rhodium states it comes from Hermann Emde's Ephedrine Chemistry Treatise and it can be partly found at: erowid.org/archive/rhodium/chemistry/ephedrine.html at the end...
My first request of something so i hope i made it as rules state....
Thank you
lugh
- Global Moderator
- Foundress Queen
- Posts: 876
All five of Emde's ephedrine articles were made available on Rhodium's web site in deja vu format long ago Some have been translated into English:
https://the-collective.ws/forum/index.php?topic=198.msg1459#msg1459
and elsewhere on the internet The deja vu articles are attached, further translation work would best bee done by a member fluent in the language
https://the-collective.ws/forum/index.php?topic=198.msg1459#msg1459
and elsewhere on the internet The deja vu articles are attached, further translation work would best bee done by a member fluent in the language
java
- Global Moderator
- Foundress Queen
- Posts: 783
4studiesonly
Über Diastereomerie I. Konfiguration des Ephedrin
Hermann Emde
Helvetica Chimica Acta
1929, Volume 12, Issue 1, pages 365–376
DOI: 10.1002/hlca.19290120142
Über Diastereomerie I. Konfiguration des Ephedrin
Hermann Emde
Helvetica Chimica Acta
1929, Volume 12, Issue 1, pages 365–376
DOI: 10.1002/hlca.19290120142
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by coincoin
Transesterification via Baeyer–Villiger oxidation utilizing potassium peroxydisulfate (K2S2O8) in acidic media
S. Zarrabi, N. O. Mahmoodi and O. Marvi
Monatshefte für Chemie / Chemical Monthly
Volume 141, Number 8 (2010), 889-891
DOI: 10.1007/s00706-010-0338-9
Note there are two parts to this article, one is supplimentary to the study
Preparation of clay-supported Sn catalysts and application to Baeyer–Villiger oxidation
Takayoshi Hara , Moriaki Hatakeyama
Green Chem.
2012,14, 771-777
DOI: 10.1039/C2GC16437J
Transesterification via Baeyer–Villiger oxidation utilizing potassium peroxydisulfate (K2S2O8) in acidic media
S. Zarrabi, N. O. Mahmoodi and O. Marvi
Monatshefte für Chemie / Chemical Monthly
Volume 141, Number 8 (2010), 889-891
DOI: 10.1007/s00706-010-0338-9
Note there are two parts to this article, one is supplimentary to the study
Preparation of clay-supported Sn catalysts and application to Baeyer–Villiger oxidation
Takayoshi Hara , Moriaki Hatakeyama
Green Chem.
2012,14, 771-777
DOI: 10.1039/C2GC16437J
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by Sydenhams chorea
The clinical toxicology of ?-hydroxybutyrate, ?-butyrolactone and 1,4-butanediol.
Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B.
Clinical Toxicology
2012, 50(6):458-470
DOI:10.3109/15563650.2012.702218
Abstract
INTRODUCTION:
Gamma-hydroxybutyrate (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are drugs of abuse which act primarily as central nervous system (CNS) depressants. In recent years, the rising recreational use of these drugs has led to an increasing burden upon health care providers. Understanding their toxicity is therefore essential for the successful management of intoxicated patients. We review the epidemiology, mechanisms of toxicity, toxicokinetics, clinical features, diagnosis, and management of poisoning due to GHB and its analogs and discuss the features and management of GHB withdrawal.
METHODS:
OVID MEDLINE and ISI Web of Science databases were searched using the terms "GHB," "gamma-hydroxybutyrate," "gamma-hydroxybutyric acid," "4-hydroxybutanoic acid," "sodium oxybate," "gamma-butyrolactone," "GBL," "1,4-butanediol," and "1,4-BD" alone and in combination with the keywords "pharmacokinetics," "kinetics," "poisoning," "poison," "toxicity," "ingestion," "adverse effects," "overdose," and "intoxication." In addition, bibliographies of identified articles were screened for additional relevant studies including nonindexed reports. Non-peer-reviewed sources were also included: books, relevant newspaper reports, and applicable Internet resources. These searches produced 2059 nonduplicate citations of which 219 were considered relevant.
EPIDEMIOLOGY:
There is limited information regarding statistical trends on world-wide use of GHB and its analogs. European data suggests that the use of GHB is generally low; however, there is some evidence of higher use among some sub-populations, settings, and geographical areas. In the United States of America, poison control center data have shown that enquiries regarding GHB have decreased between 2002 and 2010 suggesting a decline in use over this timeframe.
MECHANISMS OF ACTION: GHB is an endogenous neurotransmitter synthesized from glutamate with a high affinity for GHB-receptors, present on both on pre- and postsynaptic neurons, thereby inhibiting GABA release. In overdose, GHB acts both directly as a partial GABA(b) receptor agonist and indirectly through its metabolism to form GABA.
TOXICOKINETICS: GHB is rapidly absorbed by the oral route with peak blood concentrations typically occurring within 1 hour. It has a relatively small volume of distribution and is rapidly distributed across the blood-brain barrier. GHB is metabolized primarily in the liver and is eliminated rapidly with a reported 20-60 minute half-life. The majority of a dose is eliminated completely within 4-8 hours. The related chemicals, 1,4-butanediol and gamma butyrolactone, are metabolized endogenously to GHB.
CLINICAL FEATURES OF POISONING: GHB produces CNS and respiratory depression of relatively short duration. Other commonly reported features include gastrointestinal upset, bradycardia, myoclonus, and hypothermia. Fatalities have been reported.
MANAGEMENT OF POISONING: Supportive care is the mainstay of management with primary emphasis on respiratory and cardiovascular support. Airway protection, intubation, and/or assisted ventilation may be indicated for severe respiratory depression. Gastrointestinal decontamination is unlikely to be beneficial. Pharmacological intervention is rarely required for bradycardia; however, atropine administration may occasionally be warranted.
WITHDRAWAL SYNDROME: Abstinence after chronic use may result in a withdrawal syndrome, which may persist for days in severe cases. Features include auditory and visual hallucinations, tremors, tachycardia, hypertension, sweating, anxiety, agitation, paranoia, insomnia, disorientation, confusion, and aggression/combativeness. Benzodiazepine administration appears to be the treatment of choice, with barbiturates, baclofen, or propofol as second line management options.
CONCLUSIONS:
GHB poisoning can cause potentially life-threatening CNS and respiratory depression, requiring appropriate, symptom-directed supportive care to ensure complete recovery. Withdrawal from GHB may continue for up to 21 days and can be life-threatening, though treatment with benzodiazepines is usually effective.[/color]
The clinical toxicology of ?-hydroxybutyrate, ?-butyrolactone and 1,4-butanediol.
Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B.
Clinical Toxicology
2012, 50(6):458-470
DOI:10.3109/15563650.2012.702218
Abstract
INTRODUCTION:
Gamma-hydroxybutyrate (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are drugs of abuse which act primarily as central nervous system (CNS) depressants. In recent years, the rising recreational use of these drugs has led to an increasing burden upon health care providers. Understanding their toxicity is therefore essential for the successful management of intoxicated patients. We review the epidemiology, mechanisms of toxicity, toxicokinetics, clinical features, diagnosis, and management of poisoning due to GHB and its analogs and discuss the features and management of GHB withdrawal.
METHODS:
OVID MEDLINE and ISI Web of Science databases were searched using the terms "GHB," "gamma-hydroxybutyrate," "gamma-hydroxybutyric acid," "4-hydroxybutanoic acid," "sodium oxybate," "gamma-butyrolactone," "GBL," "1,4-butanediol," and "1,4-BD" alone and in combination with the keywords "pharmacokinetics," "kinetics," "poisoning," "poison," "toxicity," "ingestion," "adverse effects," "overdose," and "intoxication." In addition, bibliographies of identified articles were screened for additional relevant studies including nonindexed reports. Non-peer-reviewed sources were also included: books, relevant newspaper reports, and applicable Internet resources. These searches produced 2059 nonduplicate citations of which 219 were considered relevant.
EPIDEMIOLOGY:
There is limited information regarding statistical trends on world-wide use of GHB and its analogs. European data suggests that the use of GHB is generally low; however, there is some evidence of higher use among some sub-populations, settings, and geographical areas. In the United States of America, poison control center data have shown that enquiries regarding GHB have decreased between 2002 and 2010 suggesting a decline in use over this timeframe.
MECHANISMS OF ACTION: GHB is an endogenous neurotransmitter synthesized from glutamate with a high affinity for GHB-receptors, present on both on pre- and postsynaptic neurons, thereby inhibiting GABA release. In overdose, GHB acts both directly as a partial GABA(b) receptor agonist and indirectly through its metabolism to form GABA.
TOXICOKINETICS: GHB is rapidly absorbed by the oral route with peak blood concentrations typically occurring within 1 hour. It has a relatively small volume of distribution and is rapidly distributed across the blood-brain barrier. GHB is metabolized primarily in the liver and is eliminated rapidly with a reported 20-60 minute half-life. The majority of a dose is eliminated completely within 4-8 hours. The related chemicals, 1,4-butanediol and gamma butyrolactone, are metabolized endogenously to GHB.
CLINICAL FEATURES OF POISONING: GHB produces CNS and respiratory depression of relatively short duration. Other commonly reported features include gastrointestinal upset, bradycardia, myoclonus, and hypothermia. Fatalities have been reported.
MANAGEMENT OF POISONING: Supportive care is the mainstay of management with primary emphasis on respiratory and cardiovascular support. Airway protection, intubation, and/or assisted ventilation may be indicated for severe respiratory depression. Gastrointestinal decontamination is unlikely to be beneficial. Pharmacological intervention is rarely required for bradycardia; however, atropine administration may occasionally be warranted.
WITHDRAWAL SYNDROME: Abstinence after chronic use may result in a withdrawal syndrome, which may persist for days in severe cases. Features include auditory and visual hallucinations, tremors, tachycardia, hypertension, sweating, anxiety, agitation, paranoia, insomnia, disorientation, confusion, and aggression/combativeness. Benzodiazepine administration appears to be the treatment of choice, with barbiturates, baclofen, or propofol as second line management options.
CONCLUSIONS:
GHB poisoning can cause potentially life-threatening CNS and respiratory depression, requiring appropriate, symptom-directed supportive care to ensure complete recovery. Withdrawal from GHB may continue for up to 21 days and can be life-threatening, though treatment with benzodiazepines is usually effective.[/color]
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by coincoin
Baeyer–Villiger Oxidation of Ketones with Hydrogen Peroxide Catalyzed by Chitosan-Supported Dendritic Sn Complexes
Cuilin Lia*, Ziqiang Leib
Journal of Dispersion Science and Technology
2012, Volume 33, Issue 7, pages 983-989
DOI:10.1080/01932691.2011.590434
Baeyer–Villiger Oxidation of Ketones with Hydrogen Peroxide Catalyzed by Chitosan-Supported Dendritic Sn Complexes
Cuilin Lia*, Ziqiang Leib
Journal of Dispersion Science and Technology
2012, Volume 33, Issue 7, pages 983-989
DOI:10.1080/01932691.2011.590434
Polonium
- Pupae
- Posts: 70
For RoidRage:
Integrated 3D-printed reactionware for chemical synthesis and analysis
Mark D. Symes,Philip J. Kitson,Jun Yan,Craig J. Richmond,Geoffrey J. T. Cooper,Richard W. Bowman,Turlif Vilbrand& Leroy Cronin
Nature Chemistry 4, 349–354 (2012)
doi: 10.1038/nchem.1313
Integrated 3D-printed reactionware for chemical synthesis and analysis
Mark D. Symes,Philip J. Kitson,Jun Yan,Craig J. Richmond,Geoffrey J. T. Cooper,Richard W. Bowman,Turlif Vilbrand& Leroy Cronin
Nature Chemistry 4, 349–354 (2012)
doi: 10.1038/nchem.1313
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by coincoin
Selective and Shape-Selective Baeyer–Villiger Oxidations of Aromatic Aldehydes and Cyclic Ketones with Sn-Beta Zeolites and H2O2
Chemistry - A European Journal
Volume 8, Issue 20, pages 4708–4717, October 18, 2002
DOI: 10.1002/1521-3765(20021018)8:20<4708::AID-CHEM4708>3.0.CO;2-U
Selective and Shape-Selective Baeyer–Villiger Oxidations of Aromatic Aldehydes and Cyclic Ketones with Sn-Beta Zeolites and H2O2
Chemistry - A European Journal
Volume 8, Issue 20, pages 4708–4717, October 18, 2002
DOI: 10.1002/1521-3765(20021018)8:20<4708::AID-CHEM4708>3.0.CO;2-U
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by coincoin
Unprecedented Selective Oxidation of Styrene Derivatives using a Supported Iron Oxide Nanocatalyst in Aqueous Medium
Advanced Synthesis & Catalysis
2012, Volume 354, Issue 9, pages 1707–1711
Unprecedented Selective Oxidation of Styrene Derivatives using a Supported Iron Oxide Nanocatalyst in Aqueous Medium
Advanced Synthesis & Catalysis
2012, Volume 354, Issue 9, pages 1707–1711
RoidRage
- Dominant Queen
- Posts: 386
Requested by coincoin
Styrene, Its Polymers, Copolymers and Derivatives
Gerald Oster
J. Chem. Educ., 1953, 30 (4), p 216
DOI: 10.1021/ed030p216.2
Please use the format/template provided in the first post of this thread for your future requests
Styrene, Its Polymers, Copolymers and Derivatives
Gerald Oster
J. Chem. Educ., 1953, 30 (4), p 216
DOI: 10.1021/ed030p216.2
Please use the format/template provided in the first post of this thread for your future requests
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by ncoincoin
The Clemmensen Reduction
Organic Reactions
Elmore L. Martin
DOI: 10.1002/0471264180.or001.07
......find it here, change xx to tt on link.....java
hxxp://www.google.com.mx/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDIQFjAA&url=http%3A%2F%2Flibrary.sciencemadness.org%2Flibrary%2Fbooks%2Forganic_reactions_v1.pdf&ei=rwXOUOelMeng2AXp8oCIBg&usg=AFQjCNE2T2b_CrJZNJ05BQ0lDfJ82gTEUg&sig2=6VPzxvwy0098Yg8MhMlnDg&bvm=bv.1355325884,d.b2I
The Clemmensen Reduction
Organic Reactions
Elmore L. Martin
DOI: 10.1002/0471264180.or001.07
......find it here, change xx to tt on link.....java
hxxp://www.google.com.mx/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDIQFjAA&url=http%3A%2F%2Flibrary.sciencemadness.org%2Flibrary%2Fbooks%2Forganic_reactions_v1.pdf&ei=rwXOUOelMeng2AXp8oCIBg&usg=AFQjCNE2T2b_CrJZNJ05BQ0lDfJ82gTEUg&sig2=6VPzxvwy0098Yg8MhMlnDg&bvm=bv.1355325884,d.b2I
java
- Global Moderator
- Foundress Queen
- Posts: 783
Requested by Baba_McKensey
LSD: my problem child; Plants of the gods: origins of hallucinogenic use
George B. Kauffman
J. Chem. Educ.
1982, 59 (6), p A205
DOI: 10.1021/ed059pA205
Development of luminescence spectrometry as an analytical tool
T. C. O'Haver
J. Chem. Educ.
1978, 55 (7), p 423
DOI: 10.1021/ed055p423
LSD and chemistry
J. A. Campbell
J. Chem. Educ.
1972, 49 (9), p 580
DOI: 10.1021/ed049p580
LSD - An historical reevaluation
Fatima Nunes
J. Chem. Educ.
1968, 45 (11), p 688
DOI: 10.1021/ed045p688
A chemical problem related to schizophrenia
John R. Bergen
J. Chem. Educ.
1964, 41 (3), p 168
DOI: 10.1021/ed041p168
Mental Drugs: Chemistry's Challenge to Psychotherapy
Battista, O. A.
J. Chem. Educ.
1961, 38, 8, p A550
DOI: 10.1021/ed038pA550.1
Molecules and Mental Health
Harry Green
J. Chem. Educ.
1960, 37, 8, p A486
DOI: 10.1021/ed037pA486.2
The contributions of medicinal chemistry to psychopharmacology
C. Jelleff Carr
J. Chem. Educ.
1960, 37, 4, p 192
DOI: 10.1021/ed037p192
Alkaloids: Isolation and purification
Betty Maldoni
J. Chem. Educ.
1991, 68, 8, p 700
DOI: 10.1021/ed068p700
......all the files are within the link on a zip file...java
http://filecloud.io/ri61mvos
LSD: my problem child; Plants of the gods: origins of hallucinogenic use
George B. Kauffman
J. Chem. Educ.
1982, 59 (6), p A205
DOI: 10.1021/ed059pA205
Development of luminescence spectrometry as an analytical tool
T. C. O'Haver
J. Chem. Educ.
1978, 55 (7), p 423
DOI: 10.1021/ed055p423
LSD and chemistry
J. A. Campbell
J. Chem. Educ.
1972, 49 (9), p 580
DOI: 10.1021/ed049p580
LSD - An historical reevaluation
Fatima Nunes
J. Chem. Educ.
1968, 45 (11), p 688
DOI: 10.1021/ed045p688
A chemical problem related to schizophrenia
John R. Bergen
J. Chem. Educ.
1964, 41 (3), p 168
DOI: 10.1021/ed041p168
Mental Drugs: Chemistry's Challenge to Psychotherapy
Battista, O. A.
J. Chem. Educ.
1961, 38, 8, p A550
DOI: 10.1021/ed038pA550.1
Molecules and Mental Health
Harry Green
J. Chem. Educ.
1960, 37, 8, p A486
DOI: 10.1021/ed037pA486.2
The contributions of medicinal chemistry to psychopharmacology
C. Jelleff Carr
J. Chem. Educ.
1960, 37, 4, p 192
DOI: 10.1021/ed037p192
Alkaloids: Isolation and purification
Betty Maldoni
J. Chem. Educ.
1991, 68, 8, p 700
DOI: 10.1021/ed068p700
......all the files are within the link on a zip file...java
http://filecloud.io/ri61mvos
Baba_McKensey
- Subordinate Wasp
- Posts: 109
Thanks, java. What's the password?
java
- Global Moderator
- Foundress Queen
- Posts: 783
......there is no password.....java
Baba_McKensey
- Subordinate Wasp
- Posts: 109
It asks for a password when I try to unzip it.
Wizard X
- Lord of the Realms
- Foundress Queen
- Posts: 1,224
It asks for a password when I try to unzip it.
I can confirm NO password or errors in "LSD files for Baba_McKensey .zip" using WinZip 15.0 Pro.
No errors detected in compressed data of LSD files for Baba_McKensey .zip.
Testing ...
Testing LSD files for Baba_McKensey \ OK
Testing LSD files for Baba_McKensey \A chemical problem related to schizophrenia.pdf OK
Testing __MACOSX\ OK
Testing __MACOSX\LSD files for Baba_McKensey \ OK
Testing __MACOSX\LSD files for Baba_McKensey \._A chemical problem related to schizophrenia.pdf OK
Testing LSD files for Baba_McKensey \Alkaloids- Isolation and purification.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._Alkaloids- Isolation and purification.pdf OK
Testing LSD files for Baba_McKensey \Development of luminescence spectrometry as an analytical tool.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._Development of luminescence spectrometry as an analytical tool.pdf OK
Testing LSD files for Baba_McKensey \LSD - An historical reevaluation.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._LSD - An historical reevaluation.pdf OK
Testing LSD files for Baba_McKensey \LSD and chemistry.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._LSD and chemistry.pdf OK
Testing LSD files for Baba_McKensey \LSD- my problem child- Plants of the gods- origins of hallucinogenic use.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._LSD- my problem child- Plants of the gods- origins of hallucinogenic use.pdf OK
Testing LSD files for Baba_McKensey \Mental Drugs- Chemistry's Challenge to Psychotherapy .pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._Mental Drugs- Chemistry's Challenge to Psychotherapy .pdf OK
Testing LSD files for Baba_McKensey \Molecules and Mental Health.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._Molecules and Mental Health.pdf OK
Testing LSD files for Baba_McKensey \The contributions of medicinal chemistry to psychopharmacology.pdf OK
Testing __MACOSX\LSD files for Baba_McKensey \._The contributions of medicinal chemistry to psychopharmacology.pdf OK
Baba_McKensey
- Subordinate Wasp
- Posts: 109
When I try to use Windows XP to unzip the file, it asks for a password for each pdf file. Try opening the pdf files.
lugh
- Global Moderator
- Foundress Queen
- Posts: 876
That's a Windows Zip error, try 7-zip:
http://www.7-zip.org/
which opens that archive without a password prompt
http://www.7-zip.org/
which opens that archive without a password prompt
Baba_McKensey
- Subordinate Wasp
- Posts: 109
I opened it with WinZip 15.0.